NCT02611895View on ClinicalTrials.gov

Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 22, 2016

Study Completion Date

December 31, 2016

Conditions
HIV-1 Infection
Interventions
BIOLOGICAL

HIV DNA

Quantitate the amount of HIV DNA harbored in the cytoplasm of peripheral blood CD4+ T cells

Trial Locations (1)

34295

University hospital Montpellier, Montpellier

All Listed Sponsors
collaborator

Institute of Human Genetics, France

OTHER

lead

University Hospital, Montpellier

OTHER

NCT02611895 - Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy | Biotech Hunter | Biotech Hunter